News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.

Subscribe

Santa Cruz discontinued a large number of its polyclonal products as a result of the USDA settlement that was made public May 19th 2016

Find CST Equivalent

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

Western blot analysis of extracts from HT29 cells, either untreated or treated with indicated concentration of paclitaxel using Phospho-Cdc25C (Thr48) Antibody #9527 (upper) or control Cdc25C (5H9) Rabbit mAb Antibody #4688 (lower).

Learn more about how we get our images
Image

Product Usage Information

Paclitaxel is supplied as 1 mg powder. Store at or below -20ºC. Before use, dissolve powder in 1.15 ml DMSO to make a 1 mM paclitaxel stock solution. For working concentrations of 100 nM-1000 nM, dilute DMSO stock 1:10,000 to 1:1000. Treat cells with the desired concentration for 6-48 hours.


Storage: Store lyophilized or in solution at -20ºC, desiccated. Protect from light. In lyophilized form, the chemical is stable for 24 months. Once in solution, use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight:

853.92 g/mol


Purity:

>99.5%


Molecular Formula:

C47H51NO14


Paclitaxel belongs to the taxane family of antitumor and antileukemic agents (3). By binding to β-tubulin and promoting the assembly of microtubules, paclitaxel prevents microtubual depolymerization and blocks normal cell division (1-3). The microtubule dysfunction induced by paclitaxel results in aberrant cell mitosis and sometimes apoptosis. The IC50 of paclitaxel-induced mitotic block is 4 nM (4).


1.  Rowinsky, E.K. et al. (1990) J. Natl. Cancer Inst. 82, 1247-1259.

2.  Jordan, A. et al. (1998) Med. Res. Rev. 18, 259-296.

3.  Abal, M. et al. (2003) Curr Cancer Drug Targets 3, 193-203.

4.  Long, B.H. and Fairchild, C.R. (1994) Cancer Res. 54, 4355-4361.



For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

9807
Paclitaxel